Treatment of Moderate-Severe Atopic Dermatitis: Line 6 Stop 2 Pathophysiology

Share it with your friends Like

Thanks! Share it with your friends!


For the complete activity, visit:

In this activity, Alan Fleischer, Jr, MD, and Lindsay Strowd, MD, discuss the evolution in targeted treatments for atopic dermatitis based on improved understanding of pathophysiologic mechanisms. Supported by patient vignettes, they provide strategies for assessing the patient disease burden and its importance in developing an individualized treatment plan. Suggestions for greater patient engagement and improved self-management are also provided. The role and use of evidence-based nonpharmacologic and pharmacologic therapies are reviewed, focusing on dupilumab, for moderate-severe atopic dermatitis.



Comments are disabled for this post.

p26*********COMPENSATION DISCLOSURE******** Unless otherwise expressly stated, you should assume that the links contained on this site may be affiliate links and the author will earn commission if you click on them and buy the product / service mentioned in this post. However the author disclaim any liability that may result from your involvement with any such websites/products. You should perform due diligence before buying mentioned products or services. We recommend this site to visit (Click Here)

Many Thanks For Visiting Our Video Blog. ***** Share The Love!